Therapy News and Research

RSS

Scientists have induced human insulin-producing cells of the pancreas to revert to islet precursor cells

Scientists at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) have induced human insulin-producing cells of the pancreas to revert to islet precursor cells.

29 Nov 2004

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

ALS is an incurable, paralyzing neurodegenerative disorder that strikes 5 persons in every 100,000. The disease commonly affects healthy people in the most active period of their lives − without warning or previous family history.

29 Nov 2004

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

Results of a randomised trial from Uganda in this week’s issue of THE LANCET suggest that the drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria in terms of efficacy and cost-effectiveness in this region.

29 Nov 2004

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.

24 Nov 2004

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.

24 Nov 2004

European regulators should avoid excessive legislation when trying to tackle obesity

European regulators should avoid excessive legislation when trying to tackle the increasing problem of overweight groups in their population, according to a new study by Austrian researchers published today by the Brussels think-tank the European Enterprise Institute (EEI).

24 Nov 2004

Scientists have given blind nerve cells the ability to detect light

Scientists at the University of California, Berkeley, have given "blind" nerve cells the ability to detect light, paving the way for an innovative therapy that could restore sight to those who have lost it through disease.

24 Nov 2004

Study links a novel protein pathway to the aggressive progression of breast cancer

Cytogen Corporation today announced the publication of a study linking a novel protein pathway to the aggressive progression of breast cancer.

24 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Together with an international research team, researchers from VTT Technical Research Centre of Finland have developed an effective method for the screening and identification of genes that under normal conditions suppress cancer growth.

24 Nov 2004

Researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer

A team of Danish researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer in the body. This finding may be the first step towards preventing deaths due to cancer spreading to other parts of the body.

23 Nov 2004

Women now making up nearly half of the 37.2 million adults (aged 15-49) living with HIV worldwide

A new report released today shows that the number of women living with HIV has risen in each region of the world over the past two years, with the steepest increases in East Asia, followed by Eastern Europe and Central Asia. In East Asia, there was a 56% increase over the past two years, followed by Eastern Europe and Central Asia with 48%.

23 Nov 2004

Battle of Waterloo could help doctors fight death from multiple organ failure

Waterloo’s battlefield is reigniting the debate about whether modern medicine is always good for you, according to University College London (UCL) scientists who are launching a study of why some critically ill patients recover and others die from multiple organ failure - the number one killer of patients in intensive care.

23 Nov 2004

New study examines whiplash injuries

If you happen to be looking left or right when your car is rear-ended, you could be lucky enough to avoid the headache of whiplash.

23 Nov 2004

Breast conserving therapy safe for hereditary breast cancer

Women with hereditary breast cancer treated with breast conserving therapy appear to have no increased risk for recurrence in the treated breast, according to results from a prospective study published in the January 1, 2005 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

23 Nov 2004

Stem cells' repair skills could be link to cancer

Johns Hopkins researchers say there is growing evidence that stem cells gone awry in their efforts to repair tissue damage could help explain why long-term irritation, such as from alcohol or heartburn, can create a breeding ground for certain cancers.

23 Nov 2004

Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.

23 Nov 2004

FDA approves Tarceva (erlotinib)

OSI Pharmaceuticals and Genentech have announced that the U.S. Food and Drug Administration (FDA) has approved, after priority review, Tarceva (erlotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.

20 Nov 2004

Premature infants with lung disease may continue to require replacement substance to ease breathing

Physicians have known for decades that many premature babies suffer respiratory problems stemming from insufficiency of a lung substance called surfactant during their first few weeks of life.

20 Nov 2004

Transcranial Magnetic Stimulation to treat major depression

Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.

20 Nov 2004

Therapy News and Research

Scientists have induced human insulin-producing cells of the pancreas to revert to islet precursor cells

New possibilities for the use of VEGF in the treatment of Amyotrophic Lateral Sclerosis

Drug combination of amodiaquine and sulfadoxinepyrimethamine might offer the optimal treatment for malaria

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

European regulators should avoid excessive legislation when trying to tackle obesity

Scientists have given blind nerve cells the ability to detect light

Study links a novel protein pathway to the aggressive progression of breast cancer

FDA approval of Tysabri, for the treatment of multiple sclerosis

Discovery of a new cancer gene, which, when damaged, may promote prostate cancer

Researchers have discovered that by blocking a specific enzyme, it is possible to check the spread of cancer

Women now making up nearly half of the 37.2 million adults (aged 15-49) living with HIV worldwide

Battle of Waterloo could help doctors fight death from multiple organ failure

New study examines whiplash injuries

Breast conserving therapy safe for hereditary breast cancer

Stem cells' repair skills could be link to cancer

Patients taking the lipid-lowering medications have a relatively low risk of developing rhabdomyolysis

FDA approves Tarceva (erlotinib)

Premature infants with lung disease may continue to require replacement substance to ease breathing

Transcranial Magnetic Stimulation to treat major depression

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News